Brain Damage in Refractory Status Epilepticus Is 10x Worse Than Other Seizure Disorders
NfL biomarker levels in NORSE patients were 10-fold higher in CSF and 4-fold higher in serum than other seizure disorders, signaling massive neuroaxonal injury.
562 articles in this topic
NfL biomarker levels in NORSE patients were 10-fold higher in CSF and 4-fold higher in serum than other seizure disorders, signaling massive neuroaxonal injury.
A 9-day intranasal insulin regimen restored working memory, recognition memory, and reduced neuroinflammation in mice engineered to mimic hippocampal aging.
Leading neurologists argue that amyloid aggregation dynamics may be distorting how we read clinical trial results for Alzheimer's immunotherapies.
A multi-omics subspace-merging algorithm identifies biologically distinct AD subtypes, pointing toward personalized treatment strategies.
A newly identified GABAergic pathway in mice lets the brain toggle between updated and previous memories — a key insight for memory disorders.
A molecular atlas of the mouse olfactory system reveals how social odor signals are spatially organized from nose to brain.
New review maps how α-synuclein assays may detect Parkinson's before symptoms appear — and what stands between lab and clinic.
A new Cell Metabolism study reveals how oxidative stress triggers astrocytes to produce collagen, forming barriers that kill neurons after stroke.
A new review reveals that disrupted mito-nuclear signaling may precede amyloid and tau pathology, opening fresh therapeutic targets for Alzheimer's.
AI framework Reti-Pioneer screens for seven systemic diseases from a retinal photo, outperforming standard lab tests in speed and accuracy.
How you spend your 24 hours — sleeping, sitting, or moving — determines your baseline brain function and exercise responsiveness.
A Framingham study of 2,844 adults links impaired endothelial function to higher Alzheimer's risk, brain shrinkage, and white matter damage.